RhumbLine Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $162M | Sell |
418,359
-20,255
| -5% | -$7.51M | 0.12% | 121 |
|
|
2026
Q1 | $128M | Sell |
438,614
-2,383
| -0.5% | -$783K | 0.11% | 159 |
|
|
2025
Q4 | $155M | Sell |
440,997
-3,012
| -0.7% | -$1.02M | 0.13% | 126 |
|
|
2025
Q3 | $143M | Buy |
444,009
+1,155
| +0.3% | +$359K | 0.12% | 140 |
|
|
2025
Q2 | $172M | Sell |
442,854
-21,506
| -5% | -$8.65M | 0.15% | 113 |
|
|
2025
Q1 | $202M | Sell |
464,360
-2,677
| -0.6% | -$1.07M | 0.19% | 92 |
|
|
2024
Q4 | $172M | Sell |
467,037
-12,731
| -3% | -$5.33M | 0.15% | 101 |
|
|
2024
Q3 | $249M | Sell |
479,768
-14,468
| -3% | -$7.73M | 0.23% | 71 |
|
|
2024
Q2 | $268M | Sell |
494,236
-1,381
| -0.3% | -$730K | 0.25% | 66 |
|
|
2024
Q1 | $257M | Buy |
495,617
+8,102
| +2% | +$4.03M | 0.25% | 69 |
|
|
2023
Q4 | $230M | Sell |
487,515
-2,104
| -0.4% | -$973K | 0.24% | 72 |
|
|
2023
Q3 | $213M | Sell |
489,619
-4,599
| -0.9% | -$2.09M | 0.25% | 69 |
|
|
2023
Q2 | $220M | Buy |
494,218
+6,190
| +1% | +$2.86M | 0.25% | 70 |
|
|
2023
Q1 | $224M | Buy |
488,028
+14,044
| +3% | +$6.68M | 0.28% | 66 |
|
|
2022
Q4 | $243M | Buy |
473,984
+13,297
| +3% | +$6.75M | 0.33% | 57 |
|
|
2022
Q3 | $209M | Sell |
460,687
-3,320
| -0.7% | -$1.59M | 0.31% | 53 |
|
|
2022
Q2 | $224M | Buy |
464,007
+65,363
| +16% | +$32.3M | 0.33% | 56 |
|
|
2022
Q1 | $196M | Sell |
398,644
-34,655
| -8% | -$15.8M | 0.25% | 72 |
|
|
2021
Q4 | $201M | Sell |
433,299
-5,566
| -1% | -$2.34M | 0.25% | 74 |
|
|
2021
Q3 | $164M | Sell |
438,865
-10,202
| -2% | -$3.88M | 0.22% | 82 |
|
|
2021
Q2 | $171M | Sell |
449,067
-27,333
| -6% | -$10.4M | 0.23% | 79 |
|
|
2021
Q1 | $171M | Sell |
476,400
-38,429
| -7% | -$12.4M | 0.23% | 77 |
|
|
2020
Q4 | $165M | Sell |
514,829
-5,124
| -1% | -$1.57M | 0.23% | 77 |
|
|
2020
Q3 | $140M | Sell |
519,953
-8,568
| -2% | -$2.31M | 0.22% | 85 |
|
|
2020
Q2 | $139M | Buy |
528,521
+1,021
| +0.2% | +$272K | 0.23% | 80 |
|
|
2020
Q1 | $120M | Sell |
527,500
-3,121
| -0.6% | -$851K | 0.25% | 74 |
|
|
2019
Q4 | $160M | Sell |
530,621
-33,120
| -6% | -$9.11M | 0.27% | 66 |
|
|
2019
Q3 | $135M | Buy |
563,741
+21,141
| +4% | +$5.79M | 0.25% | 77 |
|
|
2019
Q2 | $153M | Buy |
542,600
+38,820
| +8% | +$10.6M | 0.29% | 63 |
|
|
2019
Q1 | $145M | Sell |
503,780
-9,330
| -2% | -$2.7M | 0.28% | 64 |
|
|
2018
Q4 | $135M | Buy |
513,110
+11,270
| +2% | +$3.1M | 0.29% | 64 |
|
|
2018
Q3 | $138M | Buy |
501,840
+3,757
| +0.8% | +$975K | 0.27% | 70 |
|
|
2018
Q2 | $119M | Sell |
498,083
-11,426
| -2% | -$2.65M | 0.24% | 78 |
|
|
2018
Q1 | $112M | Buy |
509,509
+13,469
| +3% | +$3.16M | 0.23% | 81 |
|
|
2017
Q4 | $112M | Sell |
496,040
-2,734
| -0.5% | -$582K | 0.23% | 87 |
|
|
2017
Q3 | $94.7M | Sell |
498,774
-3,549
| -0.7% | -$675K | 0.21% | 95 |
|
|
2017
Q2 | $94.5M | Buy |
502,323
+14,091
| +3% | +$2.53M | 0.22% | 89 |
|
|
2017
Q1 | $80.7M | Buy |
488,232
+7,130
| +1% | +$1.13M | 0.19% | 106 |
|
|
2016
Q4 | $69.2M | Buy |
481,102
+32,512
| +7% | +$4.35M | 0.18% | 117 |
|
|
2016
Q3 | $56.2M | Buy |
448,590
+9,212
| +2% | +$1.19M | 0.15% | 133 |
|
|
2016
Q2 | $57.7M | Buy |
439,378
+24,477
| +6% | +$3.35M | 0.17% | 118 |
|
|
2016
Q1 | $57.7M | Buy |
414,901
+8,995
| +2% | +$1.2M | 0.18% | 111 |
|
|
2015
Q4 | $56.6M | Sell |
405,906
-2,730
| -0.7% | -$376K | 0.18% | 112 |
|
|
2015
Q3 | $57.2M | Buy |
408,636
+44,553
| +12% | +$6.7M | 0.19% | 103 |
|
|
2015
Q2 | $59.8M | Sell |
364,083
-68,398
| -16% | -$10.9M | 0.19% | 106 |
|
|
2015
Q1 | $66.8M | Sell |
432,481
-12,676
| -3% | -$1.8M | 0.19% | 106 |
|
|
2014
Q4 | $55.9M | Sell |
445,157
-2,956
| -0.7% | -$365K | 0.16% | 134 |
|
|
2014
Q3 | $53.6M | Sell |
448,113
-8,774
| -2% | -$1.01M | 0.16% | 136 |
|
|
2014
Q2 | $49.2M | Sell |
456,887
-27,859
| -6% | -$2.87M | 0.14% | 157 |
|
|
2014
Q1 | $48.3M | Sell |
484,746
-19,416
| -4% | -$1.76M | 0.14% | 152 |
|
|
2013
Q4 | $46.6M | Sell |
504,162
-34,811
| -6% | -$3.09M | 0.14% | 154 |
|
|
2013
Q3 | $45.1M | Sell |
538,973
-11,260
| -2% | -$965K | 0.14% | 148 |
|
|
2013
Q2 | $45M | Buy |
+550,233
| New | +$41.2M | 0.14% | 142 |
|
Other funds holding ELV
RhumbLine Advisers's ELV Position: Q2 2026 in Review
RhumbLine Advisers reduced its Elevance Health (ELV) stake by 4.6% in Q2 2026, selling an estimated $7.51M and leaving 418,359 shares worth $162M. The position accounts for 0.12% of the portfolio, ranked #121.
RhumbLine Advisers first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $268M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- RhumbLine Advisers held 418,359 shares of Elevance Health worth $162M as of Q2 2026.
- RhumbLine Advisers sold 20,255 Elevance Health shares in Q2 2026, an estimated $7.51M.
- Elevance Health made up 0.12% of RhumbLine Advisers's portfolio in Q2 2026, its #121 holding.
- RhumbLine Advisers first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Elevance Health position peaked at $268M in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.